Mohammed Rassool to Oxazolidinones
This is a "connection" page, showing publications Mohammed Rassool has written about Oxazolidinones.
Connection Strength
0,217
-
A phase IIb, open-label, randomized controlled dose ranging multi-centre trial to evaluate the safety, tolerability, pharmacokinetics and exposure-response relationship of different doses of delpazolid in combination with bedaquiline delamanid moxifloxacin in adult subjects with newly diagnosed, uncomplicated, smear-positive, drug-sensitive pulmonary tuberculosis. Trials. 2023 Jun 06; 24(1):382.
Score: 0,217